Imron T. Aly

Partner

Imron is a trial lawyer who has served as lead counsel for clients on dozens of matters, and has first-chaired more than 15 trials. 

Imron Aly Portrait

Imron’s practice is focused on patent infringement litigation and he is viewed as a go-to trial lawyer. He has litigated and tried patent infringement and other IP matters related to pharmaceuticals, medical implants and devices, DNA arrays, mechanical production assemblies, computer business methods, and financial trading systems.

Clients and leading industry publications describe Imron as a prepared courtroom advocate whose “tenacity sets him apart,” who “stands out for his pure advocacy skills,” and “is an untiring advocate for his clients’ cause.” In the 2020 Chambers USA guide, clients commended his litigation capabilities, saying, “He is very technically sophisticated, extraordinarily persuasive and an extremely effective trial counsel.”

Client Work

  • Hospira, Inc. v. Fresenius Kabi USA, LLC (Successfully represented Fresenius  Kabi in a  groundbreaking appeal that not only benefited the client’s generic version of Precedex, but further developed the “inherent obviousness” case law for generic drugs. For this case, Schiff’s IP practice received the Hatch-Waxman Impact Case of the Year award in 2020 by LMG Life Sciences.)
  • Fresenius Kabi USA, LLC v. FERA Pharmaceuticals, LLC (Successfully represented Fresenius Kabi in obtaining a rare preliminary injunction in federal district court. The injunction barred our client’s competitor from launching a generic version of its patented formulation of levothyroxine, an injectable thyroid hormone. The District Court for the District of New Jersey granted the injunction on the basis that our client was likely to win its patent lawsuit against its competitor.)
  • Nexus Pharmaceuticals, Inc. v. Nevakar Injectables, Inc. (Leading Nexus’s efforts to address compounding companies who sell unapproved versions of Nexus’s FDA-approved ready-to-use ephedrine sulfate product.)
    • Accordion Toggle

Previous Work

Imron’s career has focused on IP litigation, including at two large Chicago-based law firms. He also served as a law clerk for the Honorable Ann K. Covington, Missouri Supreme Court, from 1999-2000.

Professional Activities

  • Guest Lecturer, Patent Litigation, University of Michigan (2011, 2013)
  • Imron has represented indigent clients on a pro bono basis in trademark and copyright, contract dispute, landlord-tenant, prisoner rights, and elder abuse matters.

Boards, Memberships & Certifications

  • Center for Biosimilars, Advisory Board Member
  • Chicago Committee, Former Board Member
  • Metropolitan Tenants Organization, Former Board Member

Publications, Presentations & Recognitions

    Publications

    • “Strategic Considerations When Managing and Protecting Disruptive Technologies,” Managing Intellectual Property Innovation and Litigation Summit 2019, San Francisco , Calif. (Jun. 11, 2019)
    • “Judge Allows Alternative Biologics Challenge,” Schiff Hardin Insight (Mar. 24, 2015)
    • “Myriad Faces Yet Another Patent Eligibility Battle In Return to the Federal Circuit,” Schiff Hardin Insight (Oct. 8, 2014)
      • Accordion Toggle

    Recognitions

    • The Best Lawyers in America, Best Lawyers (2022-2024)
    • IAM Patent 1000: The World’s Leading Patent Professionals, Patent Litigation, Illinois, IAM (2014-2022, 2024)
    • Illinois Super Lawyers, Thomson Reuters (2015-2022)
      • Accordion Toggle

    Insights

    Awards

    Firm Logo